Carlos A Jiménez Ruiz

Summary

Country: Spain

Publications

  1. ncbi Harm reduction--a treatment approach for resistant smokers with tobacco-related symptoms
    Carlos Jiménez-Ruiz
    Department of Pulmonology, Hospital Princesa, Madrid, Spain
    Respiration 69:452-5. 2002
  2. ncbi [Study of prevalence and attitudes on smoking in patients on continuous home oxygen therapy. Toma study]
    Carlos A Jiménez-Ruiz
    Unidad Especializada en Tabaquismo, Comunidad de Madrid, Spain
    Arch Bronconeumol 46:580-6. 2010
  3. ncbi [Smoking. Analysis of the scientific production in the SEPAR smoking area in 2009]
    Carlos A Jiménez Ruiz
    Comité Ejecutivo del Area de Tabaquismo de la Sociedad Española de Neumología y Cirugía Torácica, SEPAR, Madrid, Espana
    Arch Bronconeumol 46:13-6. 2010
  4. ncbi [Care results in a specialist stop-smoking unit]
    Carlos A Jiménez Ruiz
    Unidad Especializada en Tabaquismo, Comunidad de Madrid, Madrid, Espana
    Arch Bronconeumol 45:540-4. 2009
  5. ncbi Varenicline: a novel pharmacotherapy for smoking cessation
    Carlos Jiménez-Ruiz
    Smokers Clinic, Madrid, Spain
    Drugs 69:1319-38. 2009
  6. ncbi Progressive reduction using nicotine gum as a prelude to quitting
    Carlos A Jiménez-Ruiz
    Smokers Clinic, Institute of Public Health, C Santa Cruz del Marcenado, 9 piso 2, Madrid 28015, Spain
    Nicotine Tob Res 11:847-50. 2009
  7. ncbi Study of the impact of laws regulating tobacco consumption on the prevalence of passive smoking in Spain
    Carlos A Jiménez-Ruiz
    Unidad Especializada en Tabaquismo, Sub direccion General de Prevención y Promoción de la Salud, Madrid, Spain
    Eur J Public Health 18:622-5. 2008
  8. ncbi Smoking characteristics and cessation in patients with thromboangiitis obliterans
    C A Jiménez-Ruiz
    Smokers Clinic, Institute of Public Health, Madrid, Spain
    Monaldi Arch Chest Dis 65:217-21. 2006
  9. ncbi [Nicotine replacement therapy during pregnancy]
    Carlos A Jiménez Ruiz
    Unidad Especializada en Tabaquismo, Dirección General de Salud Pública y Alimentación, Comunidad de Madrid, Madrid, Espana
    Arch Bronconeumol 42:404-9. 2006
  10. ncbi Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?
    Carlos Jiménez-Ruiz
    Unidad de Tabaquismo, Instituto de Salud Pública, Comunidad de Madrid, Spain
    Nicotine Tob Res 6:649-53. 2004

Collaborators

  • Francisco Garcia-Rio
  • Angela Ramos Pinedo
  • Rafael Gabriel
  • Miguel Torrecilla
  • Ivan Berlin
  • J F Masa
  • Marc Miravitlles
  • Juan J Soler
  • Carlos A Jiménez-Ruiz
  • Carlos Jiménez-Ruiz
  • Segismundo Solano Reina
  • José Ignacio de Granda-Orive
  • C A Jiménez-Ruiz
  • Adolfo Alonso-Arroyo
  • Francisco Garcia Rio
  • Concepción Losada Molina
  • Pilar de Lucas Ramos
  • Teresa García Carmona
  • Salvador Diaz Lobato
  • Javier de la Cruz Labrado
  • Enrique Zamora García
  • Inmaculada Ramos García
  • Juan Luís Rodríguez Hermosa
  • Antonio Martínez Verdasco
  • Ali Droghan
  • José Miguel Rodríguez González-Moro
  • Rafael Aleixandre-Benavent
  • Ana C Guerrero
  • Thomas Hering
  • Angel G Garcia
  • Agustín R Cuadrado
  • Gregorio Gonzalez Alcaide
  • Santiago Villanueva-Serrano
  • Noelia A Besada
  • Marisa M Ulibarri
  • Juan Carlos Valderrama-Zurián
  • Francisco Carrión Valero
  • Angela Ramos Pinedo
  • Richard D Hurt
  • Juan Antonio Riesco Miranda
  • Rafael Aleixandre Benavent
  • Juan Carlos Valderrama Zurian
  • Santiago Villanueva Serrano
  • I de Granda Orive
  • A Guirao García
  • J Astray Mochales
  • L C Dale
  • L Velázquez Buendía
  • Lorenzo Fernández-Fau
  • José Luis Viejo
  • Carlos Villasante
  • Victor Sobradillo
  • C Villasante
  • V Sobradillo
  • Miguel Barrueco Ferrero
  • L Fernández-Fau
  • J L Viejo
  • Soledad Alonso Viteri
  • Miguel Hernández Mezquita
  • Segismundo Solano

Detail Information

Publications15

  1. ncbi Harm reduction--a treatment approach for resistant smokers with tobacco-related symptoms
    Carlos Jiménez-Ruiz
    Department of Pulmonology, Hospital Princesa, Madrid, Spain
    Respiration 69:452-5. 2002
    ..We propose that this reduction approach should be considered for patients with respiratory disease who are unable or unwilling to stop smoking...
  2. ncbi [Study of prevalence and attitudes on smoking in patients on continuous home oxygen therapy. Toma study]
    Carlos A Jiménez-Ruiz
    Unidad Especializada en Tabaquismo, Comunidad de Madrid, Spain
    Arch Bronconeumol 46:580-6. 2010
    ..The objective of this study is to analyse the prevalence, attitudes and characteristics of smoking in the population of patients subjected to Long Term Domiciliary Oxygen Therapy (LTDOT) in the Community of Madrid...
  3. ncbi [Smoking. Analysis of the scientific production in the SEPAR smoking area in 2009]
    Carlos A Jiménez Ruiz
    Comité Ejecutivo del Area de Tabaquismo de la Sociedad Española de Neumología y Cirugía Torácica, SEPAR, Madrid, Espana
    Arch Bronconeumol 46:13-6. 2010
    ....
  4. ncbi [Care results in a specialist stop-smoking unit]
    Carlos A Jiménez Ruiz
    Unidad Especializada en Tabaquismo, Comunidad de Madrid, Madrid, Espana
    Arch Bronconeumol 45:540-4. 2009
    ..To present the short, medium and long-term results of a stop-smoking clinic after 5 years of experience. The clinic was designed following the SEPAR Recommendations...
  5. ncbi Varenicline: a novel pharmacotherapy for smoking cessation
    Carlos Jiménez-Ruiz
    Smokers Clinic, Madrid, Spain
    Drugs 69:1319-38. 2009
    ..Given the greater efficacy of varenicline compared with other pharmacotherapies, and the high risk of morbidity and mortality associated with continued smoking, varenicline is a valuable pharmacological aid to smoking cessation...
  6. ncbi Progressive reduction using nicotine gum as a prelude to quitting
    Carlos A Jiménez-Ruiz
    Smokers Clinic, Institute of Public Health, C Santa Cruz del Marcenado, 9 piso 2, Madrid 28015, Spain
    Nicotine Tob Res 11:847-50. 2009
    ..7 years, SD = 12.65; mean baseline smoking = 28.3 cigarettes/day) who sought treatment in a smokers' clinic but did not want to quit abruptly...
  7. ncbi Study of the impact of laws regulating tobacco consumption on the prevalence of passive smoking in Spain
    Carlos A Jiménez-Ruiz
    Unidad Especializada en Tabaquismo, Sub direccion General de Prevención y Promoción de la Salud, Madrid, Spain
    Eur J Public Health 18:622-5. 2008
    ....
  8. ncbi Smoking characteristics and cessation in patients with thromboangiitis obliterans
    C A Jiménez-Ruiz
    Smokers Clinic, Institute of Public Health, Madrid, Spain
    Monaldi Arch Chest Dis 65:217-21. 2006
    ..Describe the smoking characteristics and the results of a smoking intervention programme involving 27 cigarette smokers with Thromboangiitis Obliterans (TAO)...
  9. ncbi [Nicotine replacement therapy during pregnancy]
    Carlos A Jiménez Ruiz
    Unidad Especializada en Tabaquismo, Dirección General de Salud Pública y Alimentación, Comunidad de Madrid, Madrid, Espana
    Arch Bronconeumol 42:404-9. 2006
    ..This article reviews the indications and contraindications for nicotine replacement therapy during pregnancy as well as other issues relating to the safety of this type of treatment...
  10. ncbi Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?
    Carlos Jiménez-Ruiz
    Unidad de Tabaquismo, Instituto de Salud Pública, Comunidad de Madrid, Spain
    Nicotine Tob Res 6:649-53. 2004
    ..Cumulative consumption of tobacco was associated with the diagnosis of COPD. For each point increase in the FTND score, the probability of a smoker developing COPD increased by 11%...
  11. ncbi [Respiratory symptoms and diagnosis of COPD in smokers of various types to tobacco. Results from the IBERPOC study]
    C A Jiménez-Ruiz
    Servicio de Neumología Hospital de la Princesa Madrid España
    Arch Bronconeumol 38:530-5. 2002
    ....
  12. ncbi Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications
    Carlos A Jiménez Ruiz
    Unidad Especializada en Tabaquismo, c Santacruz del Marcenado, 9 piso 2, Madrid 28015, Spain
    Nicotine Tob Res 14:1035-9. 2012
    ..The main objective of this study is to analyze the effectiveness and safety of drug treatments for smoking cessation in smokers with severe or very severe COPD...
  13. ncbi [Network of international scientific collaboration on smoking: analysis of coauthorship through the Science Citation Index (1999-2003)]
    José Ignacio de Granda-Orive
    Servicio de Neumologia, Hospital Central de la Defensa Gomez Ulla, Madrid, Espana
    Gac Sanit 23:222.e34-43. 2009
    ....
  14. ncbi [Spanish productivity in smoking research relative to world and European union productivity from 1999 through 2003, analyzed with the science citation index]
    José Ignacio de Granda-Orive
    Servicio de Neumologia, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain
    Arch Bronconeumol 43:212-8. 2007
    ..To analyze Spanish scientific productivity from 1999 through 2003 in the area of smoking research, in comparison with world and European Union research, based on data in the Science Citation (SCI) Index...
  15. ncbi Systemic inflammation in chronic obstructive pulmonary disease: a population-based study
    Francisco Garcia-Rio
    Pneumology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
    Respir Res 11:63. 2010
    ..The aims of this study were to compare the levels of several systemic biomarkers between stable COPD patients and healthy subjects from a population-based sample, and to assess their distribution according to clinical variables...